Bharat Biotech’s Covaxin Safe For Children Aged 2-18: Study
New Delhi: Bharat Biotech, which has a stockpile of more than 50 million doses of Covaxin ready to be distributed as required, is well-tolerated and immunogenic in the paediatric population…